Paid Clinical Trials in Albany, NY
As of July 2026, 156 paid clinical trials are recruiting in Albany, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Albany offers studies at sites including Albany Medical Center for conditions such as Obesity, Alzheimer Disease, Non-small Cell Lung Cancer, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Albany
Trials by drug in Albany
Filter results
Newly added in Albany
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
146 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
The CONFORM Pivotal Trial
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Global Paradise System US Post Approval Study
GEMINI-NSCLC: NSCLC Biomarker Study
Top Research Study Locations in Albany
Researchers run research studies in Albany, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Albany Medical Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 61 |
| Albany Medical College | Acute Ischemic Stroke, Acute Stroke, Alzheimer Disease | 18 |
| New York Oncology Hematology, P.C. | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, B-Cell Non-Hodgkins Lymphoma | 8 |
| New York Oncology Hematology | Breast Cancer, Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer | 7 |
| Capital Cardiology Associates | Aortic Stenosis, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 5 |
| Alzheimer's Disease Research Center | Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis, Moderate Alzheimer Disease | 3 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| NYOH Albany Cancer Center | Breast Neoplasms, Colonic Diseases, Colorectal Neoplasms | 2 |
| Women's Cancer Care Associates LLC | Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 2 |
| Albany MED Health System | Hematuria - Cause Not Known, Abdominal Distension, Feeding Intolerance | 2 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Albany ENT & Allergy Services | Obstructive Sleep Apnea of Adult | 1 |
| Albany Med Health System - Washington Avenue Extension | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Albany Medical Center / Capital Cardiology Associates | Atrial Fibrillation, Stroke | 1 |
| Albany Medical Center Emergency Department | Pain Management | 1 |
| Albany Medical Center Hospital | Difficult Intravenous Access, Emergency Department Patient, Midline Catheter | 1 |
| Albany Medical College Committee of Research Involving Human Subjects | End Stage Kidney Disease | 1 |
| Albany Medical College- Endocrinology Washington Extension | Hypothyroidism | 1 |
| Albany Stratton VA Medical Center | Breast Cancer, Colon Cancer, Lung Cancer | 1 |
| Alzheimer Disease Research Center (ADRC) | Early Alzheimer's Disease | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Capital Cardiology Associates_Albany | Heart Failure, Obesity | 1 |
| Everett Road Surgery Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Albany (2026)
Recruiting trials in Albany grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (53 active studies)
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC · Phase 3 · AstraZeneca
- A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) · Phase 3 · Merck Sharp & Dohme LLC
Cardiovascular (17 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs · Albany Medical College
Neurology & pain (16 active studies)
- Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients · Phase 2, Phase 3 · Albany Medical College
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) · Phase 4 · Alpha Cognition, Inc
Diabetes & metabolic (12 active studies)
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
HIV / STI (1 active study)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Mental health & behavior (1 active study)
- Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life · Albany Research Institute, Inc.
Common conditions studied in Albany
- Obesity (5 active studies)
- Alzheimer Disease (4 active studies)
- Non-small Cell Lung Cancer (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Breast Cancer (3 active studies)
Leading research sponsors in Albany
- Children's Oncology Group
- Albany Medical College
- National Cancer Institute (NCI)
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Albany?
There are approximately 156 recruiting clinical trials in Albany, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Albany pay participants?
Most recruiting trials in Albany compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Albany?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Albany?
The most common conditions under active study in Albany include Obesity (5), Alzheimer Disease (4), Non-small Cell Lung Cancer (4), Acute Myeloid Leukemia (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Albany?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Albany on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Albany?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Albany?
Recruiting research sites in Albany include Albany Medical Center, Albany Medical College, New York Oncology Hematology, P.C., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Albany right now?
The largest active categories in Albany are Cancer & tumors (53), Cardiovascular (17), Neurology & pain (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.